Candice Brady, DO
Foot and Ankle Surgery · Camarillo, CANPI 1124368667
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $330,035 of the $461,841 with a category attached, or 71.5%. Amgen accounts for 96.0% of it on its own, with 33 other manufacturers making up the rest. Among foot and ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 873 payments — averaging $529.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$443K
- Arthrex$4K
- UCB SA$3K
- Treace Medical Concepts, Inc.$2K
- Life Spine, Inc.$1K
- Micromed Inc$1K
- plus $7K from 28 others
What the payments were for
- Consulting fees$2,7601%
- Speaking & faculty fees$330,03571%
- Travel & lodging$101,49922%
- Food & beverage$22,8055%
- Education$4,7411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 694 | $443,321 |
| Arthrex | 17 | $4,059 |
| UCB SA | 1 | $2,760 |
| Treace Medical Concepts, Inc. | 15 | $2,112 |
| Life Spine, Inc. | 9 | $1,430 |
| Micromed Inc | 1 | $1,200 |
| Nexus Spine, LLC | 3 | $1,151 |
| Novo Nordisk | 23 | $619 |
| UCB, Inc. | 6 | $590 |
| Abbott | 4 | $555 |
| Radius Health, Inc. | 38 | $526 |
| Goode Surgical Inc | 4 | $523 |
| Stryker(2 entities) | 9 | $514 |
| Boston Scientific | 12 | $415 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $253 |
| Gilead | 2 | $250 |
| Bioventus LLC | 3 | $244 |
| AbbVie | 2 | $193 |
| Medtronic | 2 | $155 |
| Crossroads Extremity Systems, LLC | 1 | $147 |
| Si-bone, Inc. | 3 | $142 |
| Nevro Corp. | 2 | $108 |
| AstraZeneca | 1 | $102 |
| Carbofix Orthopedics Inc | 2 | $79 |
| Forte Bio-pharma LLC | 2 | $78 |
| Trimed, Inc. | 1 | $54 |
| Endogastric Solutions, Inc | 1 | $52 |
| Ossur Americas, Inc. | 2 | $46 |
| Zimmer Biomet | 1 | $44 |
| DJO, LLC | 1 | $30 |
| Avanos Medical | 1 | $29 |
| Johnson & Johnson | 1 | $22 |
| Paragon 28, Inc. | 1 | $20 |
| Zyla Life Sciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$357,008
- Prolia$71,262
- Lapiplasty System$1,726
- AVATAR MINIMALLY INVASIVE SPINAL SYSTEM$1,138
- PRO-LINK STAND-ALONE CERVICAL SPACER SYSTEM$1,138
- ProLift$998
- TruLift$998
- Proclaim Family of SCS IPGs$302
- Wegovy$250
- Axium Sheath Braided DRG$177
- Saturn$150
- TARSA-LINK$150
- NeXus$148
- COLLAGEN MENISCAL IMPLANT$140
- AQUAMANTYS$140
- DYNA-LINK STAND-ALONE ANTERIOR LUMBAR SYSTEM$140
- GENERAL PAIN MANAGEMENT$136
- AUGMENT$129
- Descovy$125
- iFuse Implant$108
How this compares
$461,841 in reported general payments places this provider in the 95th percentile of 1,126 foot and ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 52 | $140,971 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 31 | $73,352 |
| ProliaDenosumab | 29 | $45,967 |
| Ibandronate Sodium | 32 | $918 |
| Risedronate Sodium | 13 | $153 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $148 |
| Meloxicam | 110 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $526 | $140,97152 claims |
| AmgenEvenity (2 Syringes), Prolia | $443,321 | $119,31960 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,126 foot and ankle surgery providers in California.
Other foot and ankle surgery in Camarillo
- Hai-En PengCamarillo$33K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
- Joseph ParkBurbank$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.